Search research articles
Contact Us
Filters
Showing results (31-40 of 91) with videos related to
Page
of 10
Sort By:
British Journal of Haematology
|
February 26, 2026
Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia
Nihar Desai, Mohammed Althobaiti, Carol Chen, et al.
European Journal of Haematology
|
July 18, 2023
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission
Tommy Alfaro Moya, Jonas Mattsson, Mats Remberger, et al.
Transplantation and Cellular Therapy
|
March 10, 2024
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
Ayman Sayyed, Carol Chen, Armin Gerbitz, et al.
British Journal of Haematology
|
August 27, 2025
A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation
Nihar Desai, Sergio Rodriguez-Rodriguez, Eshrak Al-Shaibani, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 6, 2021
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients
Eshrak Al-Shaibani, Rhida Bautista, Jeffrey H Lipton, et al.
European Journal of Haematology
|
December 14, 2025
Eltrombopag in Treating Post-Allogeneic Hematopoietic Stem Cell Transplantation Cytopenias: Efficacy, Response Durability, and Cost Benefit of Early Drug Tapering
Rawan Al-Omari, Ram Vasudevan Nampoothiri, Ali Sakhdari, et al.
European Journal of Haematology
|
May 8, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms
Nihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen, et al.
European Journal of Haematology
|
December 14, 2021
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donors
Igor Novitzky-Basso, Mats Remberger, Carol Chen, et al.
Transplantation and Cellular Therapy
|
August 1, 2022
Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients
Muneyoshi Kimura, Victor H Ferreira, Sagar Kothari, et al.
Annals of Hematology
|
February 23, 2023
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience
Eshrak Al-Shaibani, Shiyi Chen, Carol Chen, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 91) with videos related to
Sort By:
Page
of 10
British Journal of Haematology
|
February 26, 2026
Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia
Nihar Desai, Mohammed Althobaiti, Carol Chen, et al.
European Journal of Haematology
|
July 18, 2023
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission
Tommy Alfaro Moya, Jonas Mattsson, Mats Remberger, et al.
Transplantation and Cellular Therapy
|
March 10, 2024
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
Ayman Sayyed, Carol Chen, Armin Gerbitz, et al.
British Journal of Haematology
|
August 27, 2025
A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation
Nihar Desai, Sergio Rodriguez-Rodriguez, Eshrak Al-Shaibani, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 6, 2021
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients
Eshrak Al-Shaibani, Rhida Bautista, Jeffrey H Lipton, et al.
European Journal of Haematology
|
December 14, 2025
Eltrombopag in Treating Post-Allogeneic Hematopoietic Stem Cell Transplantation Cytopenias: Efficacy, Response Durability, and Cost Benefit of Early Drug Tapering
Rawan Al-Omari, Ram Vasudevan Nampoothiri, Ali Sakhdari, et al.
European Journal of Haematology
|
May 8, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms
Nihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen, et al.
European Journal of Haematology
|
December 14, 2021
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donors
Igor Novitzky-Basso, Mats Remberger, Carol Chen, et al.
Transplantation and Cellular Therapy
|
August 1, 2022
Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients
Muneyoshi Kimura, Victor H Ferreira, Sagar Kothari, et al.
Annals of Hematology
|
February 23, 2023
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience
Eshrak Al-Shaibani, Shiyi Chen, Carol Chen, et al.
Page
of 10